Every AI newsletter, investors ask questions on the investor interaction platform: does your company enjoy 37% of the sales equity of Zhejiang Garden Bio-Chemical High-Tech Co.Ltd(300401) valsartan amlodipine tablets (I)?
Baicheng Pharmaceutical (301096. SZ) said on the investor interaction platform on December 24 that the company holds 37% equity of valsartan amlodipine tablets (I). After the varieties are listed and sold, it will further thicken the company’s performance. From January to June 2021, the company obtained the equity share of valsartan amlodipine tablets from Huayuan Pharmaceutical Co., Ltd. of RMB 12.6216 million (including tax).
(Daily Economic News)
